Moonlight Therapeutics is developing treatments for people suffering from food allergies. Our first treatment is focused on peanut allergies.
Location: United States, Atlanta
Investors 2
Date | Name | Website |
- | Georgia Re... | gra.org |
21.09.2024 | AllerFund | allerfund.... |
Mentions in press and media 7
Date | Title | Description |
10.07.2023 | Moonlight Therapeutics Receives Clinical Trial Grant to Evaluate MOON101 for Peanut Allergy | “This award provides validation for the scientific approach Moonlight is taking and will facilitate the company’s entry into clinical trials.” - Dr. James Baker MD. Founding Director of the Mary H. Weiser Food Allergy Center at University o... |
18.01.2022 | Moonlight Therapeutics completes pre-IND meeting with FDA | “The feedback from the FDA was encouraging and we will now prepare to submit our IND in order to evaluate the safety and tolerability of MOON101 in peanut allergic adults and children,” said Samir Patel, Moonlight Therapeutics co-founder an... |
23.07.2020 | Today at MedCity INVEST: Healthcare investment strategies amidst a pandemic and biopharma startups compete | This week we are hosting our annual MedCity INVEST conference online. Today’s agenda includes a panel discussion on investment trends and the biopharma track of the Pitch Perfect contest. The conference kicked off July 20 and concludes on F... |
24.06.2020 | Meet biopharma finalists for MedCity virtual INVEST event: Register now for Earlybird tickets while they last | Our annual INVEST conference will be held as a virtual event this year. We will highlight the seismic changes in healthcare from July 20-24 and spotlight top startups and growth stage companies and how healthcare innovation is contending wi... |
- | Today at MedCity INVEST: Healthcare investment strategies amidst a pandemic and biopharma startups compete | This week we are hosting our annual MedCity INVEST conference online. Today’s agenda includes a panel discussion on investment trends and the biopharma track of the Pitch Perfect contest. The conference kicked off July 20 and concludes on F... |
- | Moonlight Therapeutics | “Moonlight Therapeutics is a pre-clinical stage biotech company founded to develop a transformational peanut allergy therapy.” |
- | Meet biopharma finalists for MedCity virtual INVEST event: Register now for Earlybird tickets while they last | Our annual INVEST conference will be held as a virtual event this year. We will highlight the seismic changes in healthcare from July 20-24 and spotlight top startups and growth stage companies and how healthcare innovation is contending wi... |